Research progress of neurofilament light chain in the parkinsonism

李春雨,肖一,张灵语,欧汝威,商慧芳
DOI: https://doi.org/10.3760/cma.j.cn113694-20201105-00848
2021-01-01
Abstract:Neurofilament light chain (NfL), a sensitive biomarker of axonal damage, was found increasing in several neurological diseases. Parkinsonism is a group of clinical syndromes characterized by cardinal symptoms of bradykinesia, rigidity, and tremor, including Parkinson′s disease (PD) and parkinsonism plus syndrome (PPS). It is difficult in the diagnosis and differential diagnosis of PD and PPS, especially in the early stage. Evidence suggests that NfL in the cerebrospinal fluid and blood is a promising biomarker for the differential diagnosis of PD and PPS. This article reviewed and summarized the research progress of value of NfL in PD and PPS, and proposed future research directions.
What problem does this paper attempt to address?